Medtronic Net Profit Margin 2012-2026 | MDT
Current and historical net profit margin for Medtronic (MDT) from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue. Medtronic net profit margin for the three months ending April 30, 2026 was .
| Medtronic Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2026-04-30 | $36.36B | $4.80B | 13.20% |
| 2026-01-31 | $35.48B | $4.61B | 13.00% |
| 2025-10-31 | $34.76B | $4.76B | 13.71% |
| 2025-07-31 | $34.20B | $4.66B | 13.63% |
| 2025-04-30 | $33.54B | $4.66B | 13.90% |
| 2025-01-31 | $33.20B | $4.26B | 12.83% |
| 2024-10-31 | $33.00B | $4.29B | 13.00% |
| 2024-07-31 | $32.58B | $3.93B | 12.05% |
| 2024-04-30 | $32.36B | $3.68B | 11.36% |
| 2024-01-31 | $32.32B | $4.20B | 13.00% |
| 2023-10-31 | $31.96B | $4.10B | 12.84% |
| 2023-07-31 | $31.56B | $3.62B | 11.47% |
| 2023-04-30 | $31.23B | $3.76B | 12.03% |
| 2023-01-31 | $30.77B | $4.06B | 13.20% |
| 2022-10-31 | $30.81B | $4.32B | 14.03% |
| 2022-07-31 | $31.07B | $5.21B | 16.75% |
| 2022-04-30 | $31.69B | $5.04B | 15.90% |
| 2022-01-31 | $31.79B | $4.91B | 15.46% |
| 2021-10-31 | $31.80B | $4.70B | 14.79% |
| 2021-07-31 | $31.60B | $3.88B | 12.29% |
| 2021-04-30 | $30.12B | $3.61B | 11.97% |
| 2021-01-31 | $27.93B | $2.89B | 10.36% |
| 2020-10-31 | $27.87B | $3.54B | 12.69% |
| 2020-07-31 | $27.93B | $4.41B | 15.80% |
| 2020-04-30 | $28.91B | $4.79B | 16.56% |
| 2020-01-31 | $31.06B | $5.32B | 17.11% |
| 2019-10-31 | $30.89B | $4.67B | 15.11% |
| 2019-07-31 | $30.67B | $4.42B | 14.41% |
| 2019-04-30 | $30.56B | $4.63B | 15.16% |
| 2019-01-31 | $30.56B | $4.92B | 16.10% |
| 2018-10-31 | $30.38B | $2.26B | 7.44% |
| 2018-07-31 | $29.95B | $3.16B | 10.56% |
| 2018-04-30 | $29.95B | $3.10B | 10.36% |
| 2018-01-31 | $29.73B | $2.81B | 9.44% |
| 2017-10-31 | $29.64B | $5.02B | 16.93% |
| 2017-07-31 | $29.93B | $4.12B | 13.75% |
| 2017-04-30 | $29.71B | $4.03B | 13.56% |
| 2017-01-31 | $29.36B | $3.97B | 13.51% |
| 2016-10-31 | $29.01B | $4.24B | 14.62% |
| 2016-07-31 | $28.73B | $3.65B | 12.70% |
| 2016-04-30 | $28.83B | $3.54B | 12.27% |
| 2016-01-31 | $28.57B | $2.43B | 8.52% |
| 2015-10-31 | $25.95B | $2.32B | 8.92% |
| 2015-07-31 | $23.26B | $2.62B | 11.28% |
| 2015-04-30 | $20.26B | $2.68B | 13.20% |
| 2015-01-31 | $17.52B | $3.12B | 17.83% |
| 2014-10-31 | $17.37B | $2.91B | 16.75% |
| 2014-07-31 | $17.20B | $2.98B | 17.35% |
| 2014-04-30 | $17.01B | $3.07B | 18.02% |
| 2014-01-31 | $16.90B | $3.59B | 21.22% |
| 2013-10-31 | $16.76B | $3.81B | 22.74% |
| 2013-07-31 | $16.67B | $3.56B | 21.34% |
| 2013-04-30 | $16.59B | $3.47B | 20.90% |
| 2013-01-31 | $16.43B | $3.49B | 21.23% |
| 2012-10-31 | $16.32B | $3.44B | 21.05% |
| 2012-07-31 | $16.25B | $3.66B | 22.53% |
| 2012-04-30 | $16.18B | $3.62B | 22.35% |
| 2012-01-31 | $15.86B | $3.40B | 21.45% |
| 2011-10-31 | $15.80B | $3.39B | 21.47% |
| 2011-07-31 | $15.68B | $3.09B | 19.69% |
| 2011-04-30 | $15.51B | $3.10B | 19.96% |
| 2011-01-31 | $15.30B | $3.28B | 21.40% |
| 2010-10-31 | $15.30B | $3.18B | 20.80% |
| 2010-07-31 | $15.23B | $3.48B | 22.87% |
| 2010-04-30 | $15.39B | $3.10B | 20.13% |
| 2010-01-31 | $15.45B | $2.25B | 14.54% |
| 2009-10-31 | $15.09B | $2.11B | 14.00% |
| 2009-07-31 | $14.83B | $1.79B | 12.09% |
| 2009-04-30 | $14.60B | $2.07B | 14.18% |
| 2009-01-31 | $14.63B | $2.69B | 18.37% |
| 2008-10-31 | $14.54B | $2.07B | 14.22% |
| 2008-07-31 | $14.09B | $2.19B | 15.51% |
| 2008-04-30 | $13.52B | $2.14B | 15.82% |
| 2008-01-31 | $12.94B | $2.23B | 17.24% |
| 2007-10-31 | $12.58B | $2.86B | 22.76% |
| 2007-07-31 | $12.53B | $2.88B | 22.97% |
| 2007-04-30 | $12.30B | $2.80B | 22.78% |
| 2007-01-31 | $12.09B | $2.73B | 22.58% |
| 2006-10-31 | $11.81B | $2.69B | 22.77% |
| 2006-07-31 | $11.50B | $2.83B | 24.57% |
| 2006-04-30 | $11.29B | $2.55B | 22.56% |
| 2006-01-31 | $11.00B | $2.00B | 18.20% |
| 2005-10-31 | $10.76B | $1.88B | 17.44% |
| 2005-07-31 | $10.40B | $1.60B | 15.35% |
| 2005-04-30 | $10.06B | $1.81B | 17.95% |
| 2005-01-31 | $9.94B | $2.18B | 21.92% |
| 2004-10-31 | $9.61B | $2.10B | 21.85% |
| 2004-07-31 | $9.37B | $2.04B | 21.76% |
| 2004-04-30 | $9.09B | $1.96B | 21.56% |
| 2004-01-31 | $8.57B | $1.88B | 21.90% |
| 2003-10-31 | $8.29B | $1.84B | 22.21% |
| 2003-07-31 | $8.02B | $1.67B | 20.80% |
| 2003-04-30 | $7.67B | $1.60B | 20.87% |
| 2003-01-31 | $7.31B | $1.41B | 19.34% |
| 2002-10-31 | $6.99B | $1.30B | 18.61% |
| 2002-07-31 | $6.67B | $1.07B | 15.98% |
| 2002-04-30 | $6.41B | $0.99B | 15.36% |
| 2002-01-31 | $6.14B | $0.83B | 13.59% |
| 2001-10-31 | $5.91B | $0.82B | 13.92% |
| 2001-07-31 | $5.70B | $1.06B | 18.67% |
| 2001-04-30 | $5.55B | $1.05B | 18.84% |
| 2001-01-31 | $5.47B | $1.22B | 22.28% |
| 2000-10-31 | $5.36B | $1.18B | 21.91% |
| 2000-07-31 | $5.16B | $1.12B | 21.77% |
| 2000-04-30 | $4.96B | $1.09B | 21.97% |
| 2000-01-31 | $4.67B | $0.93B | 19.86% |
| 1999-10-31 | $4.48B | $0.63B | 14.16% |
| 1999-07-31 | $4.30B | $0.49B | 11.46% |
| 1999-04-30 | $4.19B | $0.47B | 11.29% |
| 1999-01-31 | $3.73B | $0.47B | 12.66% |
| 1998-10-31 | $3.29B | $0.51B | 15.58% |
| 1998-07-31 | $2.95B | $0.54B | 18.31% |
| 1998-04-30 | $2.60B | $0.46B | 17.55% |
| 1998-01-31 | $2.56B | $0.44B | 17.31% |
| 1997-10-31 | $2.53B | $0.57B | 22.36% |
| 1997-07-31 | $2.48B | $0.55B | 22.11% |
| 1997-04-30 | $2.44B | $0.53B | 21.74% |
| 1997-01-31 | $2.40B | $0.51B | 21.13% |
| 1996-10-31 | $2.33B | $0.48B | 20.81% |
| 1996-07-31 | $2.25B | $0.46B | 20.42% |
| 1996-04-30 | $2.17B | $0.43B | 19.75% |
| 1996-01-31 | $2.09B | $0.40B | 18.88% |
| 1995-10-31 | $1.98B | $0.36B | 18.17% |
| 1995-07-31 | $1.86B | $0.33B | 17.49% |
| 1995-04-30 | $1.74B | $0.29B | 16.87% |
| 1995-01-31 | $1.62B | $0.27B | 16.86% |
| 1994-10-31 | $1.54B | $0.26B | 16.82% |
| 1994-07-31 | $1.46B | $0.25B | 16.73% |
| 1994-04-30 | $1.39B | $0.23B | 16.75% |
| 1994-01-31 | $1.36B | $0.22B | 16.52% |
| 1993-10-31 | $1.33B | $0.22B | 16.18% |
| 1993-07-31 | $1.33B | $0.22B | 16.48% |
| 1993-04-30 | $1.33B | $0.21B | 15.96% |
| 1993-01-31 | $1.30B | $0.20B | 15.41% |
| 1992-10-31 | $1.30B | $0.19B | 14.83% |
| 1992-07-31 | $1.24B | $0.17B | 13.77% |
| 1992-04-30 | $1.18B | $0.16B | 13.68% |
| 1992-01-31 | $1.13B | $0.16B | 13.77% |
| 1991-10-31 | $1.09B | $0.15B | 13.90% |
| 1991-07-31 | $1.06B | $0.14B | 13.28% |
| 1991-04-30 | $1.02B | $0.13B | 13.11% |
| 1991-01-31 | $1.00B | $0.13B | 12.73% |
| 1990-10-31 | $0.95B | $0.12B | 12.59% |
| 1990-07-31 | $0.90B | $0.12B | 13.01% |
| 1990-04-30 | $0.87B | $0.11B | 12.93% |
| 1990-01-31 | $0.82B | $0.11B | 12.77% |
| 1989-10-31 | $0.80B | $0.10B | 12.72% |
| 1989-07-31 | $0.78B | $0.10B | 12.66% |
| 1989-04-30 | $0.77B | $0.10B | 13.05% |
| 1989-01-31 | $0.73B | $0.10B | 12.96% |
| 1988-10-31 | $0.71B | $0.09B | 13.04% |
| 1988-07-31 | $0.68B | $0.09B | 13.45% |
| 1988-04-30 | $0.65B | $0.09B | 13.32% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $111.968B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |